SOST and sclerosteosis: Loss of the osteocyte-specific secreted Wnt antagonist sclerostin (Van Buchem disease or sclerosteosis) or mutations in the Wnt coreceptor LRP5, which prevent binding of the Wnt antagonists sclerostin and DKK1, have been shown to cause increased bone mass.